361 related articles for article (PubMed ID: 11985366)
21. Psychosis in Parkinson's disease.
Poewe W
Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
[TBL] [Abstract][Full Text] [Related]
22. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
[TBL] [Abstract][Full Text] [Related]
23. Use of quetiapine in elderly patients.
Tariot PN; Ismail MS
J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
[TBL] [Abstract][Full Text] [Related]
24. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
[TBL] [Abstract][Full Text] [Related]
25. Clozapine treatment of psychosis in patients with Parkinson's disease.
Friedman JH
J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
[No Abstract] [Full Text] [Related]
26. Clozapine therapy for Parkinson's disease and other movement disorders.
Pfeiffer C; Wagner ML
Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
[TBL] [Abstract][Full Text] [Related]
28. Treatment of behavioural symptoms and dementia in Parkinson's disease.
Hanagasi HA; Emre M
Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
[TBL] [Abstract][Full Text] [Related]
29. When a Parkinson's disease patient starts to hallucinate.
Poewe W
Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
[TBL] [Abstract][Full Text] [Related]
30. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
Merims D; Balas M; Peretz C; Shabtai H; Giladi N
Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
[TBL] [Abstract][Full Text] [Related]
31. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
Factor SA; Molho ES; Brown DL
J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
[TBL] [Abstract][Full Text] [Related]
32. [Ziprasidone in Parkinsonian dopamine psychosis].
Durán-Ferreras E; Alvarez-López M; García-Moreno JM; Chacón J
Rev Neurol; 2008 Apr 16-30; 46(8):476-80. PubMed ID: 18428105
[TBL] [Abstract][Full Text] [Related]
33. [Psychic disorders].
Pollak P
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S125-31. PubMed ID: 12690672
[TBL] [Abstract][Full Text] [Related]
34. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
Trosch RM; Friedman JH; Lannon MC; Pahwa R; Smith D; Seeberger LC; O'Brien CF; LeWitt PA; Koller WC
Mov Disord; 1998 May; 13(3):377-82. PubMed ID: 9613725
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
Morgante L; Epifanio A; Spina E; Di Rosa AE; Zappia M; Basile G; La Spina P; Quattrone A
Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
[TBL] [Abstract][Full Text] [Related]
36. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
[TBL] [Abstract][Full Text] [Related]
37. Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.
Lancet; 1999 Jun; 353(9169):2041-2. PubMed ID: 10376627
[No Abstract] [Full Text] [Related]
38. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Reddy S; Factor SA; Molho ES; Feustel PJ
Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
[TBL] [Abstract][Full Text] [Related]
39. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K;
Mov Disord; 2001 Jan; 16(1):135-9. PubMed ID: 11215574
[TBL] [Abstract][Full Text] [Related]
40. Current use of clozapine in Parkinson disease and related disorders.
Thomas AA; Friedman JH
Clin Neuropharmacol; 2010; 33(1):14-6. PubMed ID: 20023573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
